Quantitative coronary angiography versus intravascular ultrasound guidance for drug-eluting stent implantation (GUIDE-DES): study protocol for a randomised controlled non-inferiority trial

被引:10
|
作者
Lee, Pil Hyung [1 ]
Hong, Soon Jun [2 ]
Kim, Hyun-Sook [3 ]
Yoon, Young Won [4 ]
Lee, Jong-Young [5 ]
Oh, Seung-Jin [6 ]
Kang, Soo-Jin [1 ]
Kim, Young-Hak [1 ]
Park, Seong-Wook [1 ]
Lee, Seung-Whan [1 ]
Lee, Cheol Whan [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea
[2] Korea Univ, Cardiovasc Ctr, Dept Cardiol, Anam Hosp, Seoul, South Korea
[3] Hallym Univ, Dept Cardiol, Sacred Heart Hosp, Anyang, South Korea
[4] Yonsei Univ, Gangnam Severance Hosp, Div Cardiol, Coll Med, Seoul, South Korea
[5] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Cardiol,Sch Med, Seoul, South Korea
[6] Natl Hlth Insurance Serv Ilsan Hosp, Dept Cardiol, Gyeonggi Do, South Korea
来源
BMJ OPEN | 2022年 / 12卷 / 01期
关键词
CARDIOVASCULAR ANGIOGRAPHY; MYOCARDIAL-INFARCTION; IVUS; OUTCOMES; INTERVENTION; METAANALYSIS; PREDICTORS; LESIONS; REVASCULARIZATION; DEFINITION;
D O I
10.1136/bmjopen-2021-052215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Angiography remains the gold standard for guiding percutaneous coronary intervention (PCI). However, it is prone to suboptimal stent results due to the visual estimation of coronary measurements. Although the benefit of intravascular ultrasound (IVUS)-guided PCI is becoming increasingly recognised, IVUS is not affordable for many catheterisation laboratories. Thus, a more practical and standardised angiography-based approach is necessary to support stent implantation. Methods and analysis The Quantitative Coronary Angiography versus Intravascular Ultrasound Guidance for Drug-Eluting Stent Implantation trial is a randomised, investigator-initiated, multicentre, open-label, non-inferiority trial comparing the quantitative coronary angiography (QCA)-guided PCI strategy with IVUS-guided PCI in all-comer patients with significant coronary artery disease. A novel, standardised, QCA-based PCI protocol for the QCA-guided group will be provided to all participating operators, while the PCI optimisation criteria will be predefined for both strategies. A total of 1528 patients will be randomised to either group at a 1:1 ratio. The primary endpoint is the 12-month cumulative incidence of target-lesion failure defined as a composite of cardiac death, target-vessel myocardial infarction or ischaemia-driven target-lesion revascularisation. Clinical follow-up assessments are scheduled at 1, 6 and 12 months for all patients enrolled in the study. Ethics and dissemination Ethics approval for this study was granted by the Institutional Review Board of Asan Medical Center (no. 2017-0060). Informed consent will be obtained from every participant. The study findings will be published in peer-reviewed journal articles and disseminated through public forums and academic conference presentations. Cost-effectiveness and secondary imaging analyses will be shared in secondary papers.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials
    Bavishi, Chirag
    Sardar, Partha
    Chatterjee, Saurav
    Khan, Abdur Rahman
    Shah, Arpit
    Ather, Sameer
    Lemos, Pedro A.
    Moreno, Pedro
    Stone, Gregg W.
    AMERICAN HEART JOURNAL, 2017, 185 : 26 - 34
  • [32] Biolimus-eluting Stent With Biodegradable Polymer Versus Sirolimus-eluting Stent With Durable Polymer For Coronary Revascularisation (leaders): A Randomised Non-inferiority Trial: 24 Months Follow-up
    Klauss, Volker
    Serruys, Patrick W.
    van Es, Gerri-Anne
    Buszman, Pawel
    Ischinger, Thomas
    Eberli, Franz
    Corti, Roberto
    Wijns, William
    Morice, Marie-Claude
    Di Mario, Carlo
    Schuler, Gerhard
    Linke, Axel
    Juni, Peter
    Windecker, Stephan
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : XVI - XVI
  • [33] Can stent/lesion length ratio influence the edge effect after implantation of drug-eluting and non-eluting stents?: A volumetric intravascular ultrasound study
    Muñoz, JS
    Abizaid, A
    Feres, F
    Ferreira, E
    Abizaid, AS
    Mattos, LA
    Staico, R
    Maldonado, G
    Vaz, VD
    Centemero, M
    Chaves, A
    Tanajura, LF
    Pinto, I
    Sousa, A
    Mintz, GS
    Sousa, JE
    CIRCULATION, 2004, 110 (17) : 734 - 734
  • [34] Clinical Impact of Intravascular Ultrasound Guidance in Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Disease Pooled Analysis at the Patient-Level of 4 Registries
    de la Torre Hernandez, Jose M.
    Baz Alonso, Jose A.
    Gomez Hospital, Joan A.
    Alfonso Manterola, Fernando
    Garcia Camarero, Tamara
    Gimeno de Carlos, Federico
    Roura Ferrer, Gerard
    Sanchez Recalde, Angel
    Lozano Martinez-Luengas, Inigo
    Gomez Lara, Josep
    Hernandez Hernandez, Felipe
    Perez-Vizcayno, Maria J.
    Cequier Fillat, Angel
    Perez de Prado, Armando
    Albarran Gonzalez-Trevilla, Agustin
    Jimenez Navarro, Manuel F.
    Mauri Ferre, Josepa
    Fernandez Diaz, Jose A.
    Pinar Bermudez, Eduardo
    Zueco Gil, Javier
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (03) : 244 - 254
  • [35] Intravascular Ultrasound versus Angiography Guided Drug Eluting Stent Implantation in Patients with Left Main Coronary Artery Disease - A Systematic Review and Meta-Analysis
    Karim, Kevin
    Akbar, Mohammad Rizki
    Pramudyo, Miftah
    Martha, Januar Wibawa
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (01)
  • [36] Angiographic Late Lumen Loss and Intima Hyperplasia After Sirolimus-Eluting and Zotarolimus-Eluting Stent Implantation in Diabetic Patients. The Diabetes and Drug-Eluting Stent (DiabeDES III) Intravascular Ultrasound and Angiography Trial
    Jensen, Lisette Okkels
    Maeng, Michael
    Thayssen, Per
    Villadsen, Anton
    Boetker, Hans Erik
    Krusell, Lars R.
    Pedersen, Knud Erik
    Aaroe, Jens
    Vesterlund, Thomas
    Hansen, Knud N.
    Ravkilde, Jan
    Lassen, Jens F.
    Madsen, Morten
    Tilsted, Hans H.
    Thuesen, Leif
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 138D - 139D
  • [37] Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial
    Liu, Xiao-Ming
    Yang, Zuo-Ming
    Liu, Xiao-Kun
    Zhang, Qi
    Liu, Chang-Qing
    Han, Quan-Le
    Sun, Jian-Hua
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2019, 21 (02): : 83 - 90
  • [38] HOspital care versus TELemonitoring in high-risk pregnancy (HOTEL): study protocol for a multicentre non-inferiority randomised controlled trial
    van den Heuvel, Josephus F. M.
    Ganzevoort, Wessel
    De Haan-Jebbink, Jiska M.
    van der Ham, David P.
    Deurloo, Koen L.
    Seeber, Laura
    Franx, Arie
    Bekker, Mireille N.
    BMJ OPEN, 2019, 9 (10):
  • [39] Study protocol for a non-inferiority randomised controlled trial of SKY breathing meditation versus cognitive processing therapy for PTSD among veterans
    Mathersul, Danielle C.
    Tang, Julia S.
    Schulz-Heik, R. Jay
    Avery, Timothy J.
    Seppala, Emma M.
    Bayley, Peter J.
    BMJ OPEN, 2019, 9 (04):
  • [40] Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
    Pilgrim, Thomas
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Muller, Olivier
    Vuilliomenet, Andre
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Fahrni, Therese
    Moschovitis, Aris
    Noble, Stephane
    Eberli, Franz R.
    Wenaweser, Peter
    Juni, Peter
    Windecker, Stephan
    LANCET, 2014, 384 (9960): : 2111 - 2122